Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04256551 · ClinicalTrials.gov registry record · NA
Effects of a Novel Machine Learning Mobile App on Diet Adherence in Individuals Following the Low Fodmap Diet
A NA study, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT04256551 is a NA study that has completed, run by Arizona State University. The registered enrollment target is 58 participants.
The verdict
NCT04256551, a NA study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
A high fermented, oligio-, di-, monosaccharide, and polyols (FODMAP) diet has been shown to exacerbate the symptoms of irritable bowel syndrome (IBS). Previous literature has shown significant improvement in IBS symptoms after adherence to a low FODMAP diet (LFD); hence, LFD is a viable treatment method for IBS and IBS-like symptoms. However, adherence to the LFD has proven to be difficult with participants stating that information provided by medical practitioners is generalized and nonspecific requiring them to search for supplementary information to fit their individual needs. Notably, studies that have used a combination of online and in-person methods for treatment have shown improved adherence to the LFD. The purpose of this study is to determine whether a novel machine learning dietary mobile application (ML-App) will improve adherence to the LFD compared to a standard online dietary intervention in populations with IBS or IBS-like symptoms over a 4 week period.
Interventions
- OTHER Heali mobile application + Registered Dietitian
- OTHER Heali mobile application
- OTHER Standard Dietary Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2020-01-23 |
| Est. Completion | 2020-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04256551
The ClinicalTrials.gov registry entry for NCT04256551 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Heali mobile application + Registered Dietitian is the first listed.
NCT04256551 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04256551 about?
NCT04256551 is a clinical study titled "Effects of a Novel Machine Learning Mobile App on Diet Adherence in Individuals Following the Low Fodmap Diet". A high fermented, oligio-, di-, monosaccharide, and polyols (FODMAP) diet has been shown to exacerbate the symptoms of irritable bowel syndrome (IBS). Previous literature has shown significant improvement in IBS symptoms after adherence to a low FODMAP diet (LFD); hence, LFD is a viable treatment me...
What is the current status of trial NCT04256551?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2020-01-23. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT04256551?
The interventions under investigation include: Heali mobile application + Registered Dietitian (OTHER), Heali mobile application (OTHER), Standard Dietary Education (OTHER).
Who is sponsoring clinical trial NCT04256551?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.